Hyloris Pharmaceuticals SA's market cap is currently €159.04M. The company's EPS TTM is €-0.127; its P/E ratio is ―; Hyloris Pharmaceuticals SA is scheduled to report earnings on September 25, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in EUR
Hyloris Pharmaceuticals SA Earnings and Revenue History
